Innovative Pain Management Solutions

---

Why SOLO-DEX Fascile® – the new standard of care for acute pain management?

Sophisticated design does not need to be complex. Solo-Dex was designed by anesthesiologists for anesthesiologists. Their mission: to develop the simplest, highest performing catheter for cPNB. The result, an MRI compatible, echogenic cPNB device that is inserted using one hand, by a single operator, using ultra-low doses of the local anesthetic solution, and without the need for sterile drapes or gloves. The Solo-Dex products includes a variety of catheter products suitable for various procedural applications and anatomical variation.

Solo-Dex cPNB kits are uniquely MRI compatible, contain the components required for placement, are single use, sold sterile and feature a modified Touhy tip needle, with a fenestrated, memory curve catheter, luer connectors, a filter, connector tubing, tubing blocks and catheter securement devices.

• Avoids general anesthesia risks
• Trims surgical recovery time
• Accelerates surgical discharge
• Reduces the need for opioids during start of at home recovery
• Reduces clinical costs
• Increases patient satisfaction
• Reduces surgical staff exposure to infection

Pro-Sport

Moving Your Practice to Optimal Impact

• Premier microcurrent device
• Effective non-drug, non-invasive treatment for chronic and acute pain
• Engineered, manufactured and serviced in the U.S.
• 24 modes including 19 advanced modes; five modes and ability to program patient-specific modes
• Advanced engineering allows user to control power level, pulsing action, damping, modulation and more
• Level 1 and Level 2 training allows healthcare practitioners to learn best use practices

Avazzia devices stimulate the nervous system, just as TENS devices do, but that’s where the similarity ends. Avazzia technology works differently than most TENS devices, first by using microcurrent and second by targeting the C-fibers of the nervous system (most TENS devices work on the A- and B-fibers). C-fibers stimulate the production of neuropeptides and other regulatory peptides, which the body uses to heal itself.

Because Avazzia features an interactive response, the microcurrent signal is constantly being adjusted to changes in tissue characteristics. Thus, the body does not “habituate” or “accommodate” the microcurrent signal. The device measures tissue response and adjusts the microcurrent signal. In surveys, users report that using Avazzia treatment lessens pain, improves sleep and dramatically increases users’ ability to return to daily activities.